Researcher
Mark De Ridder
- Research Expertise:
- Clinical Oncology and Radiation Oncology
- Radiobiology
- Molecular Biology
- Keywords:Medicine
- Disciplines:Radiation therapy
- Users of research expertise:
- Clinical Oncology and Radiation Oncology
- Radiobiology
- Molecular Biology
Affiliations
- Radiation Therapy (Department)
Member
From1 Jul 2013 → Today - Translational Radiation Oncology and Physics (Research group)
Responsible
From20 Oct 2010 → Today - Clinical sciences (Department)
Member
From1 Feb 2023 → Today - Clinical sciences (Department)
Member
From1 Jan 2023 → Today - Clinical sciences (Department)
Member
From1 Oct 2019 → 31 Jan 2023 - Clinical sciences (Department)
Member
From8 Apr 2019 → 31 Dec 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Clinical sciences (Department)
Responsible
From1 Jan 2014 → 20 Oct 2022 - Medical Imaging and Physical Sciences (Department)
Member
From1 Mar 2010 → 31 Dec 2013 - Radiation Therapy (Department)
Member
From1 Jan 2008 → 31 Dec 2011 - Medical Imaging and Physical Sciences (Department)
Member
From1 Oct 2001 → 30 Sep 2011
Projects
1 - 5 of 5
- RESTORE: REalistic forecaSTing, cOntrol and pREparedness for coming COVID-19 wavesFrom22 May 2020 → 21 May 2021Funding: FWO research project (including WEAVE projects)
- Uncovering the daily experiences of people with advanced cancer: adaptation and feasibility of the experience sampling methodFrom1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- SRP-Onderzoekszwaartepunt: Societal Benefit of Markerless Stereotactic Body Radiotherapy: a Statistical Support based on Quantitative ImagingFrom1 Mar 2019 → 29 Feb 2024Funding: BOF - projects
- SRP (Groeiers): Translating biological tumor signatures into image-guided radiotherapy: towards personalized treatments in rectal and lung cancerFrom1 Mar 2014 → 28 Feb 2019Funding: BOF - Concerted Research Project from 1994
- Tumor Radiosensitization by Expanded T lymphocytes: NO and CO as Molecular Determinants of Radioresponse through the IFN-γ Signalling PathwayFrom1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 144
- Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors(2021)
Authors: Eva Reijmen, Sven de Mey, Wout De Mey, Thierry Gevaert, Kirsten De Ridder, Hanne Locy, Sandrina Martens, Emmy De Blay, Luc Bouwens, P Debie, et al.
Pages: 272-283 - Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio(2021)
Authors: Vincent Vinh-Hung, Hendrik Everaert, Olena Gorobets, Hilde Van Parijs, Guy Verfaillie, Marian Vanhoeij, Guy Storme, Christel Fontaine, Jan Lamote, Justine Perrin, et al.
Pages: 956-968 - Letter to the editor regarding the article "Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: Clinical implementation and initial experience" by Intven et al(2021)
Authors: Benedikt Engels, Thierry Gevaert, Mark De Ridder
Pages: 244-245 - Pilot Study to Develop and Test Palliative Care Quality Indicators for Nursing Homes(2021)
Authors: Charlèss Dupont, Robrecht De Schreye, Joachim Cohen, Mark De Ridder, Lieve Van den Block, Luc Deliens, Kathleen Leemans
Pages: 1-15 - Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells(2020)
Authors: Sven de Mey, Inès Dufait, H. Jiang, Cyril Corbet, Hui Wang, Melissa Van De Gucht, Lisa Kerkhove, Ka Lun Law, Hugo Vandenplas, Thierry Gevaert, et al.
Pages: 1-20 - Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy(2020)
Authors: Thomas Mulliez, Kurt Barbé, Mark De Ridder
Pages: 111-116 - Two-Level Factorial Pre-TomoBreast Pilot Study of Tomotherapy and Conventional Radiotherapy in Breast Cancer(2020)
Authors: Steve Heymann, Giovanna Dipasquale, Nam P Nguyen, Meymey San, Olena Gorobets, Nicolas Leduc, Dirk Verellen, Guy Storme, Hilde Van Parijs, Mark De Ridder, et al.
- Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab(2020)
Authors: Anne Rogiers, Christophe Leys, Justine Lauwyck, Adrian Schembri, G Awada, Julia Katharina Schwarze, Jennifer De Cremer, Peter Theuns, Paul Maruff, Mark De Ridder, et al.
- Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study(2020)
Authors: Anne Rogiers, Christophe Leys, Jennifer De Cremer, G Awada, Adrian Schembri, Peter Theuns, Mark De Ridder, Bart Neyns
Pages: 3267-3278 - Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer(2020)
Authors: Karolien Vekens, Sylvia Verbanck, Christine Collen, Guy Storme, Kurt Barbé, Mark De Ridder, Eef Vanderhelst
Pages: 142–150